Dorman Products (DORM) Tops Q1 EPS by 54c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts DORM Hot Sheet
Price: $125.24 -1.76%
EPS Growth %: -23.7%
Financial Fact:
Interest expense, net: 61K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -23.7%
Financial Fact:
Interest expense, net: 61K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Dorman Products (NASDAQ: DORM) reported Q1 EPS of $2.02, $0.54 better than the analyst estimate of $1.48. Revenue for the quarter came in at $507.7 million versus the consensus estimate of $481.63 million.
GUIDANCE:
Dorman Products sees FY2025 EPS of $7.55-$7.85, versus the consensus of $7.69.
For earnings history and earnings-related data on Dorman Products (DORM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kotak Upgrades Indusind Bank Ltd (IIB:IN) to Reduce (3)
- JPMorgan Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Neutral
- ORIC Pharmaceuticals (ORIC) PT Raised to $18 at Stifel
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
